Clinical trials
Phase 2 Anemia trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Bayer | 3 |
| Novartis Pharmaceuticals | 3 |
| University of Leipzig | 3 |
| Hoffmann-La Roche | 2 |
| AMAG Pharmaceuticals, Inc. | 1 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| Celgene | 1 |
| Forma Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 25 |
| Renal Insufficiency, Chronic | 11 |
| Myelodysplastic Syndromes | 7 |
| Iron Overload | 2 |
| Kidney Failure, Chronic | 2 |
| Neutropenia | 2 |
| Anemia, Iron-Deficiency | 1 |
| Cytopenia | 1 |
| Fallopian Tube Neoplasms | 1 |
| Hemosiderosis | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.